RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
VYCIX
Price
$23.98
Change
-$0.66 (-2.68%)
Updated
Dec 18 closing price
Ad is loading...

RMFCX vs VYCIX

Header iconRMFCX vs VYCIX Comparison
Open Charts RMFCX vs VYCIXBanner chart's image
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
Voya Corporate Leaders 100 W
Price$23.98
Change-$0.66 (-2.68%)
VolumeN/A
CapitalizationN/A
RMFCX vs VYCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. VYCIX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and VYCIX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. VYCIX (1.11B). RMFCX pays higher dividends than VYCIX: RMFCX (1.69) vs VYCIX (1.59). RMFCX was incepted earlier than VYCIX: RMFCX (23 years) vs VYCIX (16 years). VYCIX is a more actively managed with annual turnover of: 29.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than VYCIX: RMFCX (250) vs VYCIX (1000). VYCIX annual gain was more profitable for investors over the last year : 15.60 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. VYCIX (24.00).
RMFCXVYCIXRMFCX / VYCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years16 years-
Gain YTD11.42314.52379%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets98.7B1.11B8,868%
Annual Yield % from dividends1.691.59106%
Returns for 1 year12.6315.6081%
Returns for 3 years14.1616.9284%
Returns for 5 years40.3924.00168%
Returns for 10 years61.8458.26106%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc